Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Best practice RWE approaches to support economic modelling for HTA

    September 10, 2024 | HTA, Health Economics, Market Access, RWE, health technology assessment, oncology, real world data, real-world evidence, rwd 

    How can real-world evidence (RWE) support health technology assessment (HTA)? Join the live webinar on Thursday 3rd October at 1.00pm (BST), featuring panellists from Mtech Access, Arcturis, and Delta Hat.

    - PMLiVE

    How can real-world evidence (RWE) support health technology assessment (HTA)? Can real-world data (RWD) supplement clinical data? How can RWE be used to solve common challenges with treatment comparison?

    On Thursday 3rd October, Mtech Access are delighted to be joined by experts from Arcturis and Delta Hat for a live webinar, where:

    • Dan Howard (Associate Director – Health Economics, Mtech Access) will share some of the challenges that our clients face when developing HTA-ready health economic models with limited clinical trial data
    • Joseph O’Reilly (Principal Medical Statistician, Arcturis) will then introduce solutions to these challenges using RWD and RWE approaches
    • Nick Latimer (Analyst, Delta Hat; Professor of Health Economics, University of Sheffield; former NICE Appraisal Committee member) will discuss how RWE is assessed by HTA committees
    • Samantha Gillard (Director – HTA, Mtech Access) will facilitate the discussion and put your questions to our experts

    Register now to join the webinar live at 1.00pm or to receive a link to the recording, to watch at your leisure.

    The panellists will explore:

    • The evidence required for health economic modelling, with a focus on partitioned survival modelling for oncology
    • Challenges posed by immature data or single-arm studies
    • How RWD can fill the gap
    • What RWD look like in practice
    • How RWD and RWE can support the HTA process
    • How RWD can be used to generate external control arms
    • Using RWD in an HTA submission – the assessor’s perspective
    Learn more about this webinar and our panellists at https://mtechaccess.co.uk/rwe-approaches-economic-modelling-hta/

    The webinar is free and open to all market access, health economics, and HTA professionals in Pharmaceutical and Medtech companies. We also welcome attendees from healthcare systems. Some colleagues from other organisations may attend at the discretion of the organisers.

    The Mtech Access Team are delighted to be presenting this webinar alongside colleagues from Arcturis and Delta Hat.

    • Arcturis use RWD and specialise in applying innovative RWE techniques to support the discovery and development of new medicines.
    • Delta Hat specialise in the technical aspects of evidence-based medicine and modelling, as well as acting as external reviewers for NICE and the Scottish Medicines Consortium (SMC).
    • Mtech Access are experts in preparing all aspects of HTA submission dossiers and health economic models.

    Register now to join us for the webinar.

    This content was provided by Petauri Evidence